Please donate here to support this vital work.
Revealing News For a Better World

Mind-Altering Drugs News Articles
Excerpts of key news articles on mind-altering drugs


Below are key excerpts of little-known, yet highly revealing news articles on mind-altering drugs from the major media. Links are provided to the full articles for verification. If any link fails to function, read this webpage. These mind-altering drugs news articles are listed by order of importance. You can also explore them listed by order of the date of the article or by the date posted. By choosing to educate ourselves, we can and will build a brighter future.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.


LSD-Like Drugs Are Out of the Haze and Back in the Labs
2016-05-15, New York Times
http://www.nytimes.com/2016/05/16/us/lsd-like-drugs-are-out-of-the-haze-and-b...

In recent years, researchers have sought to rescue hallucinogens from exile by examining their efficacy in treating certain disorders of the mind. Psychoactive substances, often derived from mushrooms, have been part of human cultures ... for thousands of years. In the 1950s and ’60s, researchers assiduously explored LSD as a tool for treating mental illness and various addictions. The Central Intelligence Agency tested the drug’s possibilities as a truth serum or perhaps a vehicle for mind control. Prohibitions against LSD and brethren hallucinogens, like psilocybin and mescaline, were codified in the Controlled Substances Act of 1970. Soon enough, serious scientific exploration of psychedelics dried up. In recent years, though, mind-bending drugs have begun tiptoeing back into the research mainstream. Modern scientists are ... studying hallucinogens’ potential to help smokers kick the habit, to undo addictions to drugs and alcohol, to cope with cluster headaches and depression, and to deal with obsessive-compulsive and post-traumatic stress disorders. Institutions where such work is underway include New York University; Johns Hopkins University; the University of California, Los Angeles; Psychiatric University Hospital in Zurich; and Imperial College in London. Hallucinogens, while not addictive, remain officially taboo everywhere. Nonetheless ... if carefully administered, [some researchers] say, hallucinogens can reorient patients’ perceptions of their place in the universe and pull them out of ruts of negative thinking.

Note: Watch a 13-minute New York Times video on the return of psychedelics as a powerful healing modality. While the war on drugs has been called a "trillion dollar failure", articles like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


How LSD Makes Your Brain One With The Universe
2016-04-13, NPR
http://www.npr.org/sections/health-shots/2016/04/13/474071268/how-lsd-makes-y...

Some users of LSD say one of the most profound parts of the experience is a deep oneness with the universe. The sensation ... correlates to changes in brain connectivity while on LSD, according to a study published Wednesday in Current Biology. An MRI scanner [showed that] the brains of people on acid looked markedly different than those on the placebo. Their sensory cortices, which process sensations like sight and touch, became far more connected than usual to the frontal parietal network, which is involved with our sense of self. "The stronger that communication, the stronger the experience of the dissolution (of self)," says Enzo Tagliazucchi, the [study's] lead author. Researchers also measured the volunteers' brain electrical activity with another device. Our brains normally generate a regular rhythm of electrical activity called the alpha rhythm, which links to our brain's ability to suppress irrelevant activity. But in a different paper published on Monday in the Proceedings of the National Academy of Sciences, he and several co-authors show that LSD weakens the alpha rhythm. He thinks this weakening could make the hallucinations seem more real. The idea is intriguing ... says Dr. Charles Grob, a psychiatrist at the Harbor-UCLA Medical Center. "They may genuinely be on to something. This should really further our understanding of the brain and consciousness." And, he says, the work highlights hallucinogens' powerful therapeutic potential.

Note: While the war on drugs has been called a "trillion dollar failure", studies like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


LSD's impact on the brain revealed in groundbreaking images
2016-04-11, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/science/2016/apr/11/lsd-impact-brain-revealed-gro...

The profound impact of LSD on the brain has been laid bare by the first modern scans of people high on the drug. The images, taken from volunteers ... revealed that trippers experienced images through information drawn from many parts of their brains. Under the drug, regions once segregated spoke to one another. Further images showed that other brain regions that usually form a network became more separated in a change that accompanied users’ feelings of oneness with the world, a loss of personal identity called “ego dissolution”. David Nutt, the government’s former drugs advisor ... and senior researcher on the study, said, “This is to neuroscience what the Higgs boson was to particle physics.” [Study co-author Robin] Carhart-Harris said, “We saw many more areas of the brain than normal were contributing to visual processing under LSD, even though volunteers’ eyes were closed.” The more prominent the effect, the more intense people rated their dreamlike visions. Under the influence, brain networks that deal with vision, attention, movement and hearing became far more connected. But at the same time, other networks broke down. The drug can be seen as reversing the more restricted thinking we develop from infancy to adulthood. The study could pave the way for LSD or related chemicals to be used to treat psychiatric disorders. Nutt said the drug could pull the brain out of thought patterns seen in depression and addiction through its effects on brain networks.

Note: For more, see an NPR article titled "How LSD Makes Your Brain One With The Universe". This ground-breaking study appears in the journal Proceedings of the National Academy of Sciences. While the war on drugs has been called a "trillion dollar failure", studies like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


LSD could make you smarter, happier and healthier.
2016-04-01, Washington Post
https://www.washingtonpost.com/posteverything/wp/2016/04/01/lsd-could-make-yo...

In 1970, Congress dropped psychedelics into the war on drugs. The federal government declared that the drugs had no medical use - and high potential for abuse. Over the past decade, some scientists have begun to challenge that conclusion. Far from being harmful, they found, hallucinogens can help sick people: They helped alcoholics drink less; terminal patients eased more gently into death. And it’s not just the infirm who are helped by the drugs. They can help us solve problems more creatively and make us more open-minded and generous. Scientists think [that] when someone takes a psychedelic, there is a decrease in blood flow and electrical activity in the brain’s “default mode network,” [which] is primarily responsible for our ego or sense of self. When we trip, our default mode network slows down. With the ego out of commission, the boundaries between self and world, subject and object dissolve. Robin Carhart-Harris, a neuroscientist with Imperial College London, notes that the default mode network is responsible for a lot of our rigid, habitual thinking and obsessions. Psychedelics help relax the part of the brain that leads us to obsess. And they can help “loosen if not break” the entrenched physical circuits responsible for addictive behavior. Steve Jobs famously said that taking LSD “was one of the most important things in my life.” The entrepreneur Tim Ferriss said that “the billionaires I know, almost without exception, use hallucinogens on a regular basis.”

Note: While the war on drugs has been called a "trillion dollar failure", articles like this suggest the healing potentials of mind altering drugs are starting to be investigated more scientifically.


Mind-Altering Drugs Could Cure PTSD
2015-12-22, Popular Science
http://www.popsci.com/mind-altering-drugs-can-cure-ptsd

About 8 percent of Americans experience PTSD; for veterans, that number is 30 percent. Treatment is notoriously difficult, but people could find relief in an unusual form: psychedelic drugs. MDMA - found in molly and ecstasy - earned a bad rap in the 1990s as ravers’ drug of choice. But psychotherapists are coming to value the way it increases empathy while decreasing fear and defensiveness. “MDMA gives people the ability to revisit an event that’s still painful without being overwhelmed,” says psychiatrist Michael Mithoefer. Following a recent MDMA trial, 83 percent of his treatment-resistant participants no longer showed symptoms of PTSD. In one study, Mithoefer worked with a New York City firefighter post-9/11. The subject had tried treatment before. While undergoing a popular method that uses eye movement to reprocess a trauma, he’d been so overcome that he ripped a sink off the wall. MDMA, however, worked. “It wasn’t easy for him,” Mithoefer says. “But our sink is still attached.” MDMA isn’t a one-trick pony either; it can treat end-of-life anxiety and alcoholism, and it’s not addictive. “We’re talking about the rise of a whole field of medicine,” says Rick Doblin, founder of the nonprofit Multidisciplinary Association for Psychedelic Studies, which is running a handful of MDMA trials, including Mithoefer’s. Doblin thinks the FDA will greenlight the drug for mainstream use by 2021.

Note: While the war on drugs has been called a "trillion dollar failure", the healing potentials of mind altering drugs are starting to be investigated more openly.


Psychedelic drugs may be ready for a medical comeback
2015-09-08, Los Angeles Times
http://www.latimes.com/science/sciencenow/la-sci-sn-psychedelic-drugs-medical...

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community, says a new analysis in the Canadian Medical Assn. Journal. For several decades, the North American medical establishment has classified psychedelic drugs – including LSD, psilocybin and [MDMA, better known as ecstasy] – as drugs of abuse with little to no medical purpose or means of safe use. That, four researchers argue, is changing. In Switzerland, Canada, Brazil, Peru, Mexico and the United States, researchers with no evident countercultural tendencies are conducting research that is finding psychedelic drugs a valuable adjunct to psychotherapy in treating addiction, post-traumatic stress and the depression or anxiety that often comes with terminal illness. Clinical investigators are demonstrating that such research "can conform to the rigorous scientific, ethical and safety standards expected of contemporary medical research," the authors write in the new analysis, titled "Psychedelic medicine: a re-emerging therapeutic paradigm." And the body of research they are generating is demonstrating that such drugs as MDMA, LSD and psilocybin can be effective in treating well-chosen patients. Two other factors - cost and time - also appear to be opening minds about the potential therapeutic uses of psychedelic drugs.

Note: For more about the therapeutic uses of psychedelic drugs, see these concise summaries of deeply revealing news articles from reliable sources.


Book review: ‘Acid Test,’ on psychedelic drug therapy for PTSD
2014-09-11, Washington Post
http://www.washingtonpost.com/opinions/book-review-acid-test-on-lsd-as-therap...

LSD, ecstasy (MDMA) and other psychedelics are powerful, mind-altering drugs that, as described by former Washington Post Magazine editor Tom Shroder, “intrinsically [challenge] the rationalist, materialist underpinnings of Western culture.” For most of a century, our society has struggled to come to grips with these “profoundly threatening drugs,” largely without success. They’ve all been made illegal. For decades, the Food and Drug Administration and the Drug Enforcement Administration have strictly banned scientific investigations into their potential benefits — which is unfortunate, since these psychoactive drugs also seem able to do incredible good, particularly in the treatment of post-traumatic stress disorder (PTSD). Every year, as many as 5 million Americans suffer from its effects. Frequent consequences include depression, drug and alcohol abuse, and a host of associated health problems. In “both humanitarian and economic terms,” the costs are staggering. And PTSD stubbornly resists treatment. Psychoactive drugs such as LSD and MDMA seem to bring powerful healing energies to bear on the underlying issues. But despite a growing mountain of evidence supporting the therapeutic benefits delivered by these drugs, government authorities have blocked scientific and therapeutic explorations of their potential. Fortunately, the government’s prohibitions may be loosening, thanks to a cadre of psychedelic advocates who have steadfastly refused to surrender to the taboos. The story of those people and their efforts to win scientific and therapeutic approval for psychedelic drugs is the central thrust of Shroder’s strangely wonderful new book, Acid Test: LSD, Ecstasy, and the Power to Heal.

Note: For more on this, see concise summaries of deeply revealing mind-altering drugs news articles from reliable major media sources.


A brief history of psychedelic psychiatry
2014-09-02, The Guardian (One of the UK's leading newspapers)
http://www.theguardian.com/science/neurophilosophy/2014/sep/02/psychedelic-ps...

On 5th May, 1953, the novelist Aldous Huxley dissolved four-tenths of a gram of mescaline in a glass of water, drank it, then sat back and waited for the drug to take effect. Huxley took the drug in his California home under the direct supervision of psychiatrist Humphry Osmond, to whom Huxley had volunteered himself as “a willing and eager guinea pig”. Osmond was one of a small group of psychiatrists who pioneered the use of LSD as a treatment for alcoholism and various mental disorders in the early 1950s. He coined the term psychedelic, meaning ‘mind manifesting’ and although his research into the therapeutic potential of LSD produced promising initial results, it was halted during the 1960s for social and political reasons. While at St. George’s [Hospital after WWII], Osmond and his colleague John Smythies learned about Albert Hoffman’s discovery of LSD at the Sandoz Pharmaceutical Company in Bazel, Switzerland. Osmond and Smythies started their own investigation into the properties of hallucinogens. Osmond tried LSD himself and concluded that the drug could produce profound changes in consciousness. Osmond and [Abram] Hoffer also recruited volunteers to take LSD and theorised that the drug was capable of inducing a new level of self-awareness which may have enormous therapeutic potential. In 1953, they began giving LSD to their patients, starting with some of those diagnosed with alcoholism. Their first study involved two alcoholic patients, each of whom was given a single 200-microgram dose of the drug. One of them stopped drinking immediately after the experiment. The other stopped 6 months later. Osmond and Hoffer were encouraged, and continued to administer the drug to alcoholics. Their studies seemed to show that a single, large dose of LSD could be an effective treatment for alcoholism, and reported that between 40 and 45% of their patients given the drug had not experienced a relapse after a year.

Note: For more on this, see concise summaries of deeply revealing mind-altering drugs news articles from reliable major media sources.


How did Alexander Shulgin become known as the Godfather of Ecstasy?
2014-06-03, The Guardian (One of the UK's leading newspapers)
http://www.theguardian.com/science/shortcuts/2014/jun/03/alexander-shulgin-ma...

The explosion of dance music culture during the late '80s and early '90s conferred fame on some unlikely people, but few were quite as unlikely as Alexander Shulgin, who died on 2 June at his home in California at the age of 88. He was nearly 70 by the time he became known as the Godfather of Ecstasy, a title that made it sound like he had invented MDMA, which he hadn't: Shulgin had only introduced the drug to west coast psychotherapists in the late 70s. But, he had created more than 200 psychoactive compounds in his home laboratory, tested them all on himself and his wife and written about them in a 1991 book titled Phenethylamines I Have Known and Loved. The combination of the book, his association with ecstasy, and that drug's burgeoning popularity made him a hugely celebrated figure. Shulgin thought all drugs should be legalised, but he seemed about as far removed from the bug-eyed psychedelic proselyte of popular myth as it was possible to get. His writing was measured, calm and witty. He did not court the attention of the rave generation. If anything, he seemed faintly exasperated by the way MDMA was being used. "Go banging about with a psychedelic drug for a Saturday night turn-on, and you can get into a really bad place, psychologically," he had warned. Later he was to lament that MDMA had been "sidetracked into the Yahoo generation". None of the drugs Shulgin invented became as famous as the one he didn't. In the late '90s, there was talk that a compound called 2CB was "the new ecstasy" but it never attained the ubiquity of E. Nevertheless, Shulgin's legend was assured.

Note: To see Shulgin's fun and iconoclastic character, watch this fun four-minute video. Explore major media articles showing breakthroughs in therapy from an excellent compilation of news articles on mind altering drugs. And read the personal journey to healing of courageous CNN reporter Amber Lyon using these "medicines."


A ‘Party Drug’ May Help the Brain Cope With Trauma
2012-11-20, New York Times
http://www.nytimes.com/2012/11/20/health/ecstasy-treatment-for-post-traumatic...

Hundreds of Iraq and Afghanistan veterans with post-traumatic stress have recently contacted a husband-and-wife team who work in suburban South Carolina to seek help. Many are desperate, pleading for treatment and willing to travel to get it. The soldiers have no interest in traditional talking cures or prescription drugs that have given them little relief. They are lining up to try an alternative: MDMA, better known as Ecstasy, a party drug that surfaced in the 1980s and ’90s that can induce pulses of euphoria and a radiating affection. Government regulators criminalized the drug in 1985, placing it on a list of prohibited substances that includes heroin and LSD. But in recent years, regulators have licensed a small number of labs to produce MDMA for research purposes. In a paper posted online ... by the Journal of Psychopharmacology, Michael and Ann Mithoefer, the husband-and-wife team offering the treatment — which combines psychotherapy with a dose of MDMA — write that they found 15 of 21 people who recovered from severe post-traumatic stress in the therapy in the early 2000s reported minor to virtually no symptoms today. The Mithoefers — he is a psychiatrist and she is a nurse — collaborated on the study with researchers at the Medical University of South Carolina and the nonprofit Multidisciplinary Association for Psychedelic Studies. The patients in this group included mostly rape victims, and experts familiar with the work cautioned that it was preliminary, based on small numbers, and its applicability to war trauma entirely unknown.

Note: For the paper on this remarkable study published published online in the Journal of Psychopharmacology, click here. For deeply revealing reports from reliable major media sources on beneficial mind-altering drugs, click here.


Marijuana Fights Cancer and Helps Manage Side Effects, Researchers Find
2012-09-06, The Daily Beast/Newsweek
http://www.thedailybeast.com/articles/2012/09/06/marijuana-fights-cancer-and-...

Mounting evidence shows ‘cannabinoids’ in marijuana slow cancer growth, inhibit formation of new blood cells that feed a tumor, and help manage pain, fatigue, nausea, and other side effects. Peer-reviewed studies in several countries ... show that THC and other marijuana-derived compounds, known as “cannabinoids,” are effective not only for cancer-symptom management (nausea, pain, loss of appetite, fatigue), they also confer a direct antitumoral effect. A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. THC treatment was associated with significantly reduced tumor cell proliferation in every test subject. Harvard University scientists reported that THC slows tumor growth in common lung cancer and “significantly reduces the ability of the cancer to spread.” What’s more ... THC selectively targets and destroys tumor cells while leaving healthy cells unscathed. Conventional chemotherapy drugs, by contrast, are highly toxic; they indiscriminately damage the brain and body. There is mounting evidence ... that cannabinoids “represent a new class of anticancer drugs that retard cancer growth, inhibit angiogenesis [the formation of new blood cells that feed a tumor] and the metastatic spreading of cancer cells.” Within the medical science community, the discovery that cannabinoids have anti-tumoral properties is increasingly recognized as a seminal advancement in cancer therapeutics.

Note: Yet treatment with cannabinoids continues to be largely illegal in the US. For an informative 15-minute documentary on the health benefits of juicing raw cannabis, click here. For deeply revealing reports from reliable major media sources on promising cancer-cure research, click here.


Can a hallucinogen from Africa cure addiction?
2012-04-13, BBC News
http://www.bbc.co.uk/news/magazine-17666589

Since the 1960s a disparate group of scientists and former drug addicts have been advocating a radical treatment for addiction - a hallucinogen called ibogaine, derived from an African plant, that in some cases seems to obliterate withdrawal symptoms from heroin, cocaine and alcohol. So why isn't it widely used? The drug, derived from the root of a central African plant called iboga, had been used for centuries by the Bwiti people of Gabon and Cameroon, as part of a tribal initiation ceremony. But it wasn't until 1962, when a young heroin addict called Howard Lotsof stumbled upon ibogaine, that its value as an addiction treatment was uncovered. Lotsof took it to get high but when the hallucinogenic effects wore off, he realised he no longer had the compulsion to take heroin. He became convinced that he had found the solution to addiction and dedicated much of his life to promoting ibogaine as a treatment. Ibogaine affects the brain in two distinct ways. The first is metabolic. It creates a protein that blocks receptors in the brain that trigger cravings, stopping the symptoms of withdrawal. With normal detox this process can take months. Its second effect is much less understood. It seems to inspire a dream-like state that is intensely introspective, allowing addicts to address issues in their life that they use alcohol or drugs to suppress.

Note: For more news articles from reliable sources on mind-altering drugs, click here.


Learning from a '50s Housewife on Acid
2011-01-18, ABC News
http://abcnews.go.com/Health/1950s-housewife-acid/story?id=12640926

A video [that went viral] featured footage of a mid-1950s housewife on an acid trip during an LSD experiment. In the film, a researcher, Dr. Sidney Cohen, is shown interviewing, and then dosing, a volunteer at the Veteran's Administration Hospital in Los Angeles. The woman, who is identified only as the wife of a hospital employee, is in her late 20s or early 30s and appears fairly typical of her time. LSD was a legal pharmaceutical drug until 1966. Journalist Don Lattin says he came across the video in the archives of philosopher Gerald Heard while researching a group biography on him, the British writer Aldous Huxley, and Bill Wilson, co-founder of Alcoholics Anonymous. In the video that Lattin posted online, [the housewife] is clearly under the influence and appears to be rather enjoying it. She says: "Everything is alive. This is reality. I wish you could see it. I wish I could talk in technicolor." "This shows that very early on in the 1950s, researchers were aware that there were possible beneficial uses, rather than military or more nefarious uses," he says. In the early 1950s and into the '60s the Army and CIA secretly funded a lot of research to see if LSD could be used as a chemical weapon or a truth serum, says Lattin. But Cohen and his ilk were pursuing a different line of study. They wanted to understand how it works, how the mind works and the connection between the psychotic state and a spiritually enlightened state." Indeed, Wilson, the AA co-founder, did a fair amount of LSD in the 50s , says Lattin. "This surprises people, but he wasn't doing it to get high," he adds. "It was to achieve that spiritual awakening."

Note: The video of this session is quite inspiring. See it at this link. For more on mind-altering drugs, see the deeply revealing reports from reliable major media sources available here.


Pont-Saint-Esprit poisoning: Did the CIA spread LSD?
2010-08-23, BBC News
http://www.bbc.co.uk/news/world-10996838

Nearly 60 years ago, a French town was hit by a sudden outbreak of hallucinations, which left five people dead and many seriously ill. On 16 August 1951, postman Leon Armunier was doing his rounds in the southern French town of Pont-Saint-Esprit when he was suddenly overwhelmed by nausea and wild hallucinations. "It was terrible. I had the sensation of shrinking and shrinking, and the fire and the serpents coiling around my arms," he remembers. Leon, now 87, fell off his bike and was taken to the hospital in Avignon. Over the coming days, dozens of other people in the town fell prey to similar symptoms. Doctors at the time concluded that bread at one of the town's bakeries had become contaminated by ergot, a poisonous fungus that occurs naturally on rye. That view remained largely unchallenged until 2009, when an American investigative journalist, Hank Albarelli, revealed a CIA document labelled: "Re: Pont-Saint-Esprit and F.Olson Files. SO Span/France Operation file, inclusive Olson. Intel files. Hand carry to Belin - tell him to see to it that these are buried." F. Olson is Frank Olson, a CIA scientist who, at the time of the Pont St Esprit incident, led research for the agency into the drug LSD. David Belin, meanwhile, was executive director of the Rockefeller Commission created by the White House in 1975 to investigate abuses carried out worldwide by the CIA. Albarelli believes the Pont-Saint-Esprit and F. Olson Files, mentioned in the document, would show - if they had not been "buried" - that the CIA was experimenting on the townspeople, by dosing them with LSD.

Note: Frank Olson later had his drink spiked with LSD and allegedly committed suicide shortly thereafter. Yet many believe he was "suicided" as he was having misgivings about his involvement in this program and considering spilling the beans, as reported in this news article. For an overview of CIA mind-control experimentation, click here.


F.D.A. Agrees to New Trials for Ecstasy as Relief for PTSD Patients
2016-11-29, New York Times
http://www.nytimes.com/2016/11/29/us/ptsd-mdma-ecstasy.html?_r=0

After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world. He had tried almost all the accepted treatments for post-traumatic stress disorder. “Nothing worked for me,” said Mr. Hardin. Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the illegal party drug better known as Ecstasy. “It changed my life,” he said. “It allowed me to see my trauma without fear or hesitation and finally process things and move forward.” Based on promising results like Mr. Hardin’s, the Food and Drug Administration gave permission Tuesday for large-scale, Phase 3 clinical trials of the drug - a final step before the possible approval of Ecstasy as a prescription drug. The Multidisciplinary Association for Psychedelic Studies, a small nonprofit created in 1985 ... sponsored six Phase 2 studies treating a total of 130 PTSD patients. Two trials ... focused on treating combat veterans, sexual assault victims, and police and firefighters with PTSD who had not responded to traditional prescription drugs or psychotherapy. Patients had, on average, struggled with symptoms for 17 years. After three doses of MDMA administered under a psychiatrist’s guidance, the patients reported a 56 percent decrease of severity of symptoms on average, one study found. By the end of the study, two-thirds no longer met the criteria for having PTSD. Follow-up examinations found that improvements lasted more than a year after therapy.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. This FDA approval to begin Phase 3 clinical trials of MDMA suggests that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


‘It can rewire people’s brains’: how traumatised veterans turned to underground MDMA therapy
2018-11-17, The Guardian (One of the UK's leading newspapers)
https://www.theguardian.com/film/2018/nov/18/it-can-rewire-peoples-brains-how...

Dead Dog on the Left isn’t just a documentary about the use of ecstasy in treating PTSD, it’s a story of the lengths one former marine will go to for friendship. [Tyler] McCourry and [Nigel] Flanigan are the subjects of [the] mini-documentary taken from a forthcoming feature film, MDMA the Movie, which explores the history of the so-called “party drug” more popularly known as ecstasy, its use in therapy, and harm reduction. Both films are directed by Emanuel Sferios. His protagonists may have survived the Iraq war, but only barely. Suicidal thoughts have stalked them both. In May 2012 McCourry did his first [MDMA-assisted psychotherapy] session ... lying in bed, flanked by two therapists. At the beginning of the session he was given a 75mg dose of MDMA. “During those eight hours you’re addressing the most challenging situations in your life,” he says. “It feels very exhausting, like it was some of the most work you’ve ever done in one day.” McCourry calls those trials, now completed, “a transformation of the psyche”. MDMA-assisted psychotherapy has “breakthrough therapy” designation by the FDA. “Since the MDMA therapy I’m able to recognise when something comes up that I need to talk about,” [McCourry] says. McCourry hopes that the therapy will be adopted by the Veterans Administration and Department of Defense. “If you can cure PTSD after three sessions of MDMA therapy then you don’t have to provide a veteran with medications for the rest of their life and talk therapy once a month.”

Note: A touching 26-documentary on this case is available at the above link. Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Magic mushrooms could replace antidepressants within five years, says new psychedelic research centre
2019-07-08, The Independent (One of the UK's leading newspapers)
https://www.independent.co.uk/news/health/magic-mushroom-depression-psychedel...

Hallucination-inducing drugs like magic mushrooms could be about to break big pharma’s stranglehold on the hugely lucrative market for antidepressants, according to the head of the world’s first centre for psychedelic research. Antidepressant prescriptions have doubled in England in a decade with around seven million adults taking the drugs, and the global market is predicted to be worth $15.9bn (Ł12.5bn) by 2023. At Imperial College London, Dr Robin Carhart-Harris is leading one of the first trials to test how therapy using psilocybin mushrooms, which are currently banned in the UK, compares to leading antidepressants. While he won’t prejudge the results of the study, he says participants describe a cathartic emotional “release” with psilocybin therapy – the polar opposite of antidepressants, which patients complain leave their emotions, whether positive or negative, “blunted”. It is the first of many studies planned under the banner of the new Centre for Psychedelic Research at London’s Imperial College. Dr James Rucker is another of those researching the potential benefits of psychedelics ... at King’s College London. The King’s team are launching two trials, one looking at whether psilocybin therapy can help people whose depression is resistant to treatment with conventional antidepressants. He says it was “possible” the drug could be licensed in five years.

Note: For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


How a trip on magic mushrooms helped decriminalize psychedelic plants in a California city
2019-06-22, Los Angeles Times
https://www.latimes.com/local/lanow/la-me-ln-oakland-decriminalize-mushrooms-...

Carlos Plazola locked himself in a bedroom while his cousin stood guard. For five hours, he tripped on magic mushrooms. He ingested 5 grams - a heady amount that connoisseurs call the “heroic dose.” It was Plazola’s first time using the mushrooms, which contain the naturally occurring hallucinogen psilocybin. He started having epiphanies, one right after the other, like lightning bolts. “I was making connections that I had never made in terms of my understanding of what we are, what the cosmos are, why we’re here, where we’re going,” Plazola said. That mushroom trip last October by Plazola, the well-connected onetime chief of staff of a former Oakland City Council president, helped make Oakland the first city in California and the second in the nation to effectively decriminalize magic mushrooms. In May, Denver became the first city in the nation to decriminalize psilocybin mushrooms. In Oakland ... the City Council on June 4 approved its ordinance unanimously, with little pushback. Oakland even went a step further by decriminalizing not just mushrooms but also a range of other psychoactive plants and compounds including peyote, iboga and ayahuasca. The measure ... does not actually legalize natural psychedelics, which remain illegal under state and federal law. Instead, it declares the arrest and investigation of adults for using, possessing, growing or distributing plant-based hallucinogens to be among the lowest priorities for local police and restricts the use of city funds to go after users.

Note: Forbes recently published an excellent article clearing up the hype about some aspects of this sensitive subject. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.


Psychedelics, long ignored by scientists, seeing resurgence in medical research
2019-06-01, San Francisco Chronicle (San Francisco's leading newspaper)
https://www.sfchronicle.com/bayarea/article/Psychedelics-long-ignored-by-scie...

UCSF psychiatrist Brian Anderson is studying an experimental therapy to help long-term AIDS survivors ... who are feeling sad and demoralized. In a clinic outfitted with a comfortable couch, soft lighting, throw pillows and blankets, the participants of his study are given psilocybin, the hallucinogenic compound found in magic mushrooms. The results were compelling enough that he’s planning a second study. Anderson’s work is part of a resurgence in psychedelic study that has been ... fueling grassroots efforts around the country to decriminalize use of certain psychedelic drugs. Statewide measures are being discussed in California and Oregon. The decriminalization efforts are focused on natural psychedelics — mushrooms, along with herbs, cacti and other plants from which hallucinogenic compounds can be extracted. Though several studies in the first half of the 20th century had shown promise in using psychedelics for treatment of mental health and neurological disorders, the drugs were broadly maligned in the 1960s and ’70s. More recently, microdosing — the practice taking small, carefully controlled amounts of a psychedelic — has taken off among Silicon Valley techies and university students who believe it boosts productivity and creativity. Almost all studies at the moment rely on private donations for funding. Studies are still limited, but they’re happening at universities around the country. At Johns Hopkins, Johnson and his colleagues reported about an 80% success rate in using psilocybin to help people quit smoking in one small study. Research out of UCLA has found that psilocybin may help cancer patients with depression and anxiety.

Note: For more along these lines, see concise summaries of deeply revealing news articles on studies of psychedelics from reliable major media sources.


Investors are starting to bet big on psychedelic medicine
2019-03-23, CNBC News
https://www.cnbc.com/2019/03/27/psychedelic-medicine-start-ups-vet-ketamine-p...

Psychedelic medicine is having a moment. Just weeks after the U.S. Food and Drug Administration approved Johnson & Johnson’s ketamine-like nasal spray for depression, a group of European technology investors ... got together for the largest-ever private financing round for a psychedelic medicine biotech company, ATAI. Psychedelic medicine involves research and investigations into mind-altering substances to treat mental illnesses including addiction, depression and post-traumatic stress disorder. After recreational use of psychedelics became popular in the 1960s, the U.S. government classified most of them “drugs of abuse” with no real medical value. However, recent clinical studies show mounting evidence that some psychedelics can help patients with certain mental illnesses, either in combination with traditional therapies or in cases where nothing else has worked. Now health and technology investors are paying attention. German company ATAI Life Sciences announced on Tuesday that it has raised more than $40 million in new financing. The round valued the company at $240 million, according to a person familiar, making it both the biggest round and the most valuable company in the young space. ATAI is currently funding clinical trials for what it refers to as “formerly stigmatized compounds,” including psilocybin, the active compound in psychedelic mushrooms, and arketamine, a different variant of ketamine from the one Johnson & Johnson researched, as potential treatments for depression.

Note: Articles like this suggest that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.


Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

Kindly donate here to support this inspiring work.

Subscribe to our free email list of underreported news.

newsarticles.media is a PEERS empowerment website

"Dedicated to the greatest good of all who share our beautiful world"